Androgen-deprivation therapy (ADT) administered in neoadjuvant setting before radical prostatectomy (RP) represents an ideal in vivo human model to test the efficacy of hormonal treatments in prostate cancer (PCa). This review summarizes the findings from published studies specifically focused on the biological effects of ADT assessed on specimens from RP. The aim is to provide a base of knowledge that might be used to design future studies on neoadjuvant therapy for PCa.
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review
Antonelli, Alessandro;Palumbo, Carlotta;Veccia, Alessandro;Grisanti, Salvatore;Triggiani, Luca;Zamboni, Stefania;Furlan, Maria;Simeone, Claudio;Magrini, Stefano;Berruti, Alfredo
2018-01-01
Abstract
Androgen-deprivation therapy (ADT) administered in neoadjuvant setting before radical prostatectomy (RP) represents an ideal in vivo human model to test the efficacy of hormonal treatments in prostate cancer (PCa). This review summarizes the findings from published studies specifically focused on the biological effects of ADT assessed on specimens from RP. The aim is to provide a base of knowledge that might be used to design future studies on neoadjuvant therapy for PCa.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
R19Y2018N04A0370.pdf
accesso aperto
Tipologia:
Full Text
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
592.7 kB
Formato
Adobe PDF
|
592.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.